Viewing Study NCT01938456


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-02-06 @ 5:29 PM
Study NCT ID: NCT01938456
Status: WITHDRAWN
Last Update Posted: 2014-07-28
First Post: 2013-09-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer, Non-Small Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-small cell lung cancer View
None GSK1120212 (trametinib) View
None Japanese View
None Phase Ib View
None combination therapy View
None docetaxel View
None MEK inhibitor View